{"name": "Talecris Biotherapeutics",
 "permalink": "talecris-biotherapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/talecris-biotherapeutics",
 "homepage_url": "http://www.talecris.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2004,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "919-316-6300",
 "description": "Biotech",
 "created_at": "Thu Sep 17 01:46:16 UTC 2009",
 "updated_at": "Thu Jul 21 19:19:28 UTC 2011",
 "overview": "\u003Cp\u003ETalecris Biotherapeutics, Inc., a biopharmaceutical company, engages in the production and marketing of plasma-derived protein therapies worldwide. It develops, produces, markets, and distributes therapies for the people suffering from chronic and acute, immune deficiency disorders, alpha-1 antitrypsin deficiency, infectious diseases, hemophilia, and severe burns. The company\u00e2\u20ac\u2122s products include Gamunex, an intravenous immune globulin (IGIV) for the treatment of primary immune deficiency and autoimmune diseases; and Prolastin, an alpha-1 proteinase inhibitor (A1PI) for the treatment of alpha-1 antitrypsin deficiency-related emphysema. It also offers Hyperimmunes, which are antibody preparations for hepatitis, rabies, tetanus, and treatment of Rh negative women pregnant with Rh positive children; and albumin under various brand names, including Plasbumin albumin and Plasmanate plasma protein factor. In addition, the company provides plasma-derived hemostasis products to treat patients who lack the necessary factors for blood clotting and suffer from conditions in which clotting occurs; and PPF-powder for the fermentation of Kogenate. Talecris Biotherapeutics, Inc. was incorporated in 2004 and is based in Research Triangle Park, North Carolina.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[140,
       46],
      "assets/images/resized/0005/9993/59993v1-max-150x150.jpg"],
     [[140,
       46],
      "assets/images/resized/0005/9993/59993v1-max-250x250.jpg"],
     [[140,
       46],
      "assets/images/resized/0005/9993/59993v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Chairman ",
    "person":
     {"first_name": "Lawrence",
      "last_name": "D. Stern",
      "permalink": "lawrence-d-stern",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "John",
      "last_name": "M. Hanson",
      "permalink": "john-m-hanson",
      "image": null}},
   {"is_past": false,
    "title": "President",
    "person":
     {"first_name": "Alberto",
      "last_name": "R. Martinez",
      "permalink": "alberto-r-martinez",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition":
  {"price_amount": 3400000000.0,
   "price_currency_code": "USD",
   "term_code": null,
   "source_url": "http://www.newsobserver.com/2011/06/02/1242024/spanish-buyer-set-to-take-over.html",
   "source_description": "Spanish buyer set to take over Talecris",
   "acquired_year": 2011,
   "acquired_month": 6,
   "acquired_day": 7,
   "acquiring_company":
    {"name": "Grifols",
     "permalink": "grifols",
     "image":
      {"available_sizes":
        [[[132,
           48],
          "assets/images/resized/0008/9965/89965v1-max-150x150.png"],
         [[132,
           48],
          "assets/images/resized/0008/9965/89965v1-max-250x250.png"],
         [[132,
           48],
          "assets/images/resized/0008/9965/89965v1-max-450x450.png"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "4101 Research Commons",
    "address2": "79 T.W. Alexander Drive",
    "zip_code": "27709",
    "city": "Research Triangle Park",
    "state_code": "NC",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "FTC deal clears path for Grifols' $4B Talecris buyout\r\n",
    "stoned_year": 2011,
    "stoned_month": 5,
    "stoned_day": 2,
    "source_url": "http://www.fiercebiotech.com/story/ftc-deal-clears-path-grifols-4b-talecris-buyout/2011-05-02?utm_medium=rss\u0026utm_source=rss",
    "source_text": "",
    "source_description": "FTC deal clears path for Grifols' $4B Talecris buyout",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Talecris Biotherapeutics",
      "permalink": "talecris-biotherapeutics"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}